Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: Design and rationale of the ROADMAP clinical trial

被引:25
|
作者
Rogers, Joseph G. [1 ]
Boyle, Andrew J. [2 ]
O'Connell, John B. [3 ]
Horstmanshof, Douglas A. [4 ]
Haas, Donald C. [5 ]
Slaughter, Mark S. [6 ]
Park, Soon J. [7 ]
Farrar, David J. [3 ]
Starling, Randall C. [8 ]
机构
[1] Duke Univ, Div Cardiol, Durham, NC 27710 USA
[2] Cleveland Clin Florida, Weston, FL USA
[3] Thoratec Corp, Pleasanton, CA USA
[4] INTEGRIS Baptist Med Ctr, Oklahoma City, OK USA
[5] Abington Mem Hosp, Abington, PA USA
[6] Univ Louisville, Louisville, KY 40292 USA
[7] Univ Hosp Case Med Ctr, Cleveland, OH USA
[8] Cleveland Clin, Cleveland, OH USA
关键词
INTERMACS ANNUAL-REPORT; CONTINUOUS-FLOW; CIRCULATORY SUPPORT; TRANSPLANTATION; SURVIVAL; OUTCOMES; REGISTRY; THERAPY; MODEL;
D O I
10.1016/j.ahj.2014.11.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Mechanical circulatory support is now a proven therapy for the treatment of patients with advanced heart failure and cardiogenic shock. The role for this therapy in patients with less severe heart failure is unknown. Objective The objective of this study is to examine the impact of mechanically assisted circulation using the HeartMate II left ventricular assist device in patients who meet current US Food and Drug Administration-defined criteria for treatment but are not yet receiving intravenous inotropic therapy. Methods This is a prospective, nonrandomized clinical trial of 200 patients treated with either optimal medical management or a mechanical circulatory support device. Clinical context This trial will be the first prospective clinical evaluation comparing outcomes of patients with advanced ambulatory heart failure treated with either ongoing medical therapy or a left ventricular assist device. It is anticipated to provide novel insights regarding relative outcomes with each treatment and an understanding of patient and provider acceptance of the ventricular assist device therapy. This trial will also provide information regarding the risk of events in "stable" patients with advanced heart failure and guidance for the optimal timing of left ventricular assist device therapy.
引用
收藏
页码:205 / +
页数:26
相关论文
共 50 条
  • [1] Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients Results From the ROADMAP Study
    Estep, Jerry D.
    Starling, Randall C.
    Horstmanshof, Douglas A.
    Milano, Carmelo A.
    Selzman, Craig H.
    Shah, Keyur B.
    Loebe, Matthias
    Moazami, Nader
    Long, James W.
    Stehlik, Josef
    Kasirajan, Vigneshwar
    Haas, Donald C.
    O'Connell, John B.
    Boyle, Andrew J.
    Farrar, David J.
    Rogers, Joseph G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : 1747 - 1761
  • [2] Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients The ROADMAP Study 2-Year Results
    Starling, Randall C.
    Estep, Jerry D.
    Horstmanshof, Douglas A.
    Milano, Carmelo A.
    Stehlik, Josef
    Shah, Keyur B.
    Bruckner, Brian A.
    Lee, Sangjin
    Long, James W.
    Selzman, Craig H.
    Kasirajan, Vigneshwar
    Haas, Donald C.
    Boyle, Andrew J.
    Chuang, Joyce
    Farrar, David J.
    Rogers, Joseph G.
    JACC-HEART FAILURE, 2017, 5 (07) : 518 - 527
  • [3] Patient-Reported Health-Related Quality of Life Is a Predictor of Outcomes in Ambulatory Heart Failure Patients Treated With Left Ventricular Assist Device Compared With Medical Management Results From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management)
    Stehlik, Josef
    Estep, Jerry D.
    Selzman, Craig H.
    Rogers, Joseph G.
    Spertus, John A.
    Shah, Keyur B.
    Chuang, Joyce
    Farrar, David J.
    Starling, Randall C.
    CIRCULATION-HEART FAILURE, 2017, 10 (06)
  • [4] Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients)
    Lanfear, David E.
    Levy, Wayne C.
    Stehlik, Josef
    Estep, Jerry D.
    Rogers, Joseph G.
    Shah, Keyur B.
    Boyle, Andrew J.
    Chuang, Joyce
    Farrar, David J.
    Starling, Randall C.
    CIRCULATION-HEART FAILURE, 2017, 10 (05)
  • [5] Assessment and Management of Heart Failure After Left Ventricular Assist Device Implantation
    Burke, Michael A.
    Givertz, Michael M.
    CIRCULATION, 2014, 129 (10) : 1161 - U197
  • [6] Roads, Maps, and Destinations: the Journey of Left Ventricular Assist Device Implantation in Ambulatory Patients with Advanced Heart Failure
    Trachtenberg, Barry H.
    Estep, Jerry D.
    CURRENT CARDIOLOGY REPORTS, 2016, 18 (12)
  • [7] Left ventricular assist device management in patients chronically supported for advanced heart failure
    Cowger, Jennifer
    Romano, Matthew A.
    Stulak, John
    Pagani, Francis D.
    Aaronson, Keith D.
    CURRENT OPINION IN CARDIOLOGY, 2011, 26 (02) : 149 - 154
  • [8] Cost-Effectiveness of Left Ventricular Assist Devices in Ambulatory Patients With Advanced Heart Failure
    Shreibati, Jacqueline Baras
    Goldhaber-Fiebert, Jeremy D.
    Banerjee, Dipanjan
    Owens, Douglas K.
    Hlatky, Mark A.
    JACC-HEART FAILURE, 2017, 5 (02) : 110 - 119
  • [9] Randomized trial of a left ventricular assist device as destination therapy versus guideline-directed medical therapy in patients with advanced heart failure. Rationale and design of the SWEdish evaluation of left Ventricular Assist Device (SweVAD) trial
    Karason, Kristjan
    Lund, Lars H.
    Dalen, Magnus
    Bjorklund, Erik
    Grinnemo, Karl
    Braun, Oscar
    Nilsson, Johan
    van der Wal, Henriette
    Holm, Jonas
    Hubbert, Laila
    Lindmark, Krister
    Szabo, Barna
    Holmberg, Erik
    Dellgren, Goran
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (04) : 739 - 750
  • [10] Assessment and Management of Right Ventricular Failure in Left Ventricular Assist Device Patients
    Holman, William L.
    Acharya, Deepak
    Siric, Franjo
    Loyaga-Rendon, Renzo Y.
    CIRCULATION JOURNAL, 2015, 79 (03) : 478 - +